Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

65.54 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
59 60 Next >
CVS Health: Earnings Beat Ignites Stock Rally
CVS Health's stock is showing upward movement after exceeding quarterly earnings expectations, suggesting a potential positive shift. 
Via MarketBeat
Topics Earnings
These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
 
Via Benzinga
CVS Showered With Upgrades, PT Hikes After Q4 Beat Powers Stock To Best Day In Over 25 Years: Retail Cheer Grows
Analysts largely believe that the company’s Aetna insurance business is set to rebound and its margins will recover soon. 
Via Stocktwits
This AstraZeneca Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
 
Via Benzinga
US Stocks Set For A Mixed Start Following Higher Inflation Print: Expert Says Earnings Remain Strong Despite Uncertainty
U.S. stock futures were mixed on Thursday after a hotter-than-expected January inflation print, which was released on Wednesday. 
Via Benzinga
Topics Economy
Market Whales and Their Recent Bets on CVS Options
 
Via Benzinga
Why CVS Health Stock Popped Today
Via The Motley Fool
Dow Dips More Than 200 Points Following Inflation Report, Megacap Tech Stocks Edge Lower: Greed Index In 'Fear' Zone
 
Via Benzinga
Topics Economy Stocks
CVS Health Forecasts 10% Earnings Growth For 2025, Citing Aetna's 'Meaningful Recovery'
CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — Aetna's turnaround. 
Via Benzinga
Breaking Down The Current Earnings Outlook
Total earnings for the 345 S&P 500 companies that have reported results are up +12.7% from the same period last year on +5.8% higher revenues, with 78.0% beating EPS estimates and 65.5% beating revenue... 
Via Talk Markets
Topics Stocks Stocks / Equities
Top S&P500 movers in Wednesday's session
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Earnings Scheduled For February 12, 2025
 
Via Benzinga
Which S&P500 stocks are the most active on Wednesday?
Stay informed about the most active stocks in the S&P500 index on Wednesday's session. Discover the stocks that are generating the highest trading volume and driving market activity. 
Via Chartmill
Nasdaq Edges Higher; CVS Health Shares Jump Following Upbeat Earnings
 
Via Benzinga
Why CVS Health (CVS) Stock Is Trading Up Today
Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 16.4% in the morning session after the company reported strong fourth-quarter results that exceeded expectations, with same-store... 
Via StockStory
These S&P500 stocks are moving in today's session
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New... 
Via Benzinga
Topics Economy
CVS Health (CVS) Q4 2024 Earnings Call Transcript
CVS earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Crude Oil Down Over 2%; Upstart Shares Jump Following Earnings
 
Via Benzinga
CVS Beats EPS Estimates, Losses Loom
CVS Health reported mixed fourth-quarter earnings, beating estimates but showing challenges in key areas. 
Via The Motley Fool
Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
Discover the top S&P500 movers in Wednesday's pre-market session.
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More
CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance set at $5.75-$6.00. 
Via Benzinga
CVS Health Surges Premarket As Q4 Earnings Blow Past Estimates, Retail Buzz Builds
The company said it continues to see growth in Pharmacy and Consumer Wellness while working to address challenges in its Health Care Benefits segment. 
Via Stocktwits
CVS Health’s (NYSE:CVS) Q4 Sales Top Estimates, Stock Soars
Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q4 CY2024, with sales up 4.2% year on year to $97.71 billion. Its non-GAAP profit of $1.19 per share was... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
US Stocks Set For A Cautious Start Ahead Of Inflation Data: Expert Says 'Strong Bull Markets Tend To Roar Back To Life After Corrections'
U.S. stock futures fell on Wednesday after a mixed close on Tuesday as Federal Reserve Chairman Jerome Powell Congress testimony. 
Via Benzinga
Topics Economy
Dow Gains Over 100 Points Following Powell Comments: Fear & Greed Index Remains In 'Neutral' Zone
 
Via Benzinga
Topics Stocks
CVS Health, Kraft Heinz And 3 Stocks To Watch Heading Into Wednesday
 
Via Benzinga
CVS Health Stock Is Relatively Cheap, Analyst Highlights Cost Trend Pressure Ahead Of Q4 Earnings
CVS Health reports Q4 earnings on Feb. 12, with analysts watching cost trends, Medicare Advantage enrollment, and medical loss ratio impacts. 
Via Benzinga
CVS Stock Approaches Q4 Earnings With Resistance In Sight
CVS Health (CVS) reports Q4 earnings on Wed. Stock is down 29.78% in past yr, up 22.72% YTD. Bullish trend but mixed signals. Analysts rate it a Buy with avg price tgt $63.67, potential 17.01% upside.... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
59 60 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.